- Functional mushrooms seeing rise in popularity due to health benefits, alternative medicine options
- Predictions show global medicinal mushroom market growing annually by $13.88 billion
- Pure Extracts is ideally positioned to enter the space as experienced producer
Used for centuries for their impressive medicinal properties and health benefits, functional mushrooms are enjoying a rise in popularity, due at least in part to increased research and study of the natural fungi as well as trends toward alternative natural health options. Pure Extract Technologies, a private, plant-based extraction company with a new vertical in functional mushrooms, is focused on becoming the dominant extraction company in the industry and a leader in the rapid development and commercialization of functional mushroom products.
In an article titled “Here’s What You Need to Know About Functional Mushroom,” Stephanie Ferrari, a Massachusetts-based registered dietitian, says that there is deep scientific literature that points to the healing properties of mushrooms, specifically their immune system and cancer-prevention benefits (http://ibn.fm/3EczB). “Research suggests that mushrooms not only strengthen our immune systems but may also be useful in treating certain diseases like asthma, allergies and arthritis due to their anti-inflammatory properties,” she says.
Beyond that, the article notes that “mushrooms are low in calories, high in protein, and good sources of B vitamins, minerals and fiber. . . . Several are considered adaptogens, which means they help us to cope with stress.”
In addition, research published in “Integrative Medicine: A Clinician’s Journal,” notes that, for certain types of mushrooms, “an abundance of in vitro evidence exists that elucidates the anticancer immunological mechanisms. Preliminary research in humans is also available and is promising for treatment” (http://ibn.fm/SGEgE).
The functional mushroom industry is among the fastest growing in North America, with forecasts predicting the global medicinal mushroom market will grow annually by $13.88 billion (http://ibn.fm/mwcrf). As the industry transitions from dry biomass to extracts, many companies are unprepared for this new opportunity.
Pure Extracts, on the other hand, is ideally positioned to enter the space as an experienced producer. With a team of qualified experts and cutting-edge extraction technology, the company is set up for long-term strategic distribution and product innovation. Located in Pemberton, British Columbia, the company’s facility is built for EU-GMP certification, which allows for international sales and ensures the production of high-quality, high-purity formulations on a commercial scale.
Further establishing its power in the market, Pure Extracts has signed nondisclosure agreements to explore joint-development endeavors for product launches slated for potential Q4 delivery. The company also inked an advisory agreement with Dr. Alexander MacGregor, founder of Transpharm Canada Inc., the parent company of Toronto Institute of Pharmaceutical Technology, whose facility is a fully compliant Health Canada-licensed, Good Manufacturing Practice manufacturing and testing facility and is a full-service, clinical-development business that provides clinical trial services to biotechnology companies.
For more information, visit the company’s website at www.PureExtractsCorp.com.
NOTE TO INVESTORS: The latest news and updates relating to Pure Extracts are available in the company’s newsroom at http://ibn.fm/Pure
